OMRF discoveries could lead to better treatment for lymphedema By Ryan Stewart Copyright © 2016, The Oklahoma Publishing Company The human lymphatic system is a network of vessels and lymph nodes that spans the entire body. Lymphatic vessels absorb tissue fluids and return them to the bloodstream. Defects in lymphatic vessels can cause lymphedema, aRead more
Oklahoma City has hit its share of biotech home runs. Alexion, the biotech giant with a market capitalization of almost $40 billion, grew out of discoveries made at the Oklahoma Medical Research Foundation. Likewise, work at the University of Oklahoma Health Sciences Center gave birth to Novazyme Pharmaceuticals, which Genzyme purchased for more than $200 million in 2001. And Myriad Genetics acquired OMRF spin-off Crescendo Biosciences in 2014 for $270 million.
In Oklahoma City, Entrepreneurs Aim to Create the Next Cool Startup Scene By Anna Hensel, Inc.com For U.S. cities looking to become the next big tech hub, it’s not enough to just recruit eager entrepreneurs. Cities also have to attract the employees (coders, designers, salespeople) who can keep the startup afloat. A fine example of oneRead more
Bioscience conference a place to highlight Oklahoma successes, opportunities By Scott Meacham Copyright © 2015 The Oklahoma Publishing Co. When i2E was asked to manage the Oklahoma BioScience Association (OKBio) a couple of years ago, we welcomed the opportunity. The promise of Oklahoma’s bioscience sector is deep and wide. The economic impact statewide of bioscienceRead more
A decade ago, Dr. Michael Centola, an Oklahoma medical researcher had an idea to assess the genomic makeup of millions of people who suffer from an inflammatory disease known as rheumatoid arthritis. Then a scientist at the Oklahoma Medical Research Foundation (OMRF), Dr. Centola founded Riley Genomic and based its operations at the Presbyterian HealthRead more
